Magnesium Stearate → Oxindole hydrazide

HRID 642174

Reaktionsgleichung

[NH2:1][NH2:2].[NH:3]1[C:11]2[C:6](=[CH:7][CH:8]=[CH:9][CH:10]=2)[CH2:5][C:4]1=[O:12].[C:13]([O-:32])(=O)CCCCCCCCCCCCCCCCC.[Mg+2].C([O-])(=O)CCCCCCCCCCCCCCCCC>>[N:3]1([C:13]([NH:1][NH2:2])=[O:32])[C:11]2[C:6](=[CH:7][CH:8]=[CH:9][CH:10]=2)[CH2:5][C:4]1=[O:12]

Komponenten

Edukt 2

HCID 11177Magnesium Stearate

HCID 68408482Oxindole hydrazine

Produkt 1

HCID 68409101Oxindole hydrazide

Versuchsvorschrift

An oxindole hydrazine derivative of formula (I) is admixed as a dry powder with a dry gelatin binder in an approximate 1:2 weight ratio. A minor amount of magnesium stearate is added as a lubricant. The mixture is formed into 240-270 mg tablets (80-90 mg of active oxindole hydrazide compound per tablet) in a tablet press.

Quellen und Nachweise

ORD-Eintrag: ord-0f563ffa44e54008ba644b72f6446303
Quelldatensatz: uspto-grants-2010_04
DOI: 10.6084/m9.figshare.5104873.v1
Patentnummer: US07696231B2

Verknüpfte Notizen

Wird geladen…